Dr. Mark Rosenberg, MD

Dr. Rosenberg attended the Univ. of Pennsylvania for his undergraduate education and then Georgetown Univ. School of Medicine for his medical training. Dr. Rosenberg did his residency training in emergency medicine at Brooke Army Medical Center and was then the Assistant Chief of Emergency Medicine at Walter Reed Army Medical Center. He left the military in 1996 with the rank of Major. During his residency, Dr. Rosenberg was awarded resident and teacher of the year and continued to teach while at Walter Reed.

Dr. Rosenberg transitioned into antiaging medicine in 1998, after attending his first A4M (American Academy of Antiaging Medicine) conference. He then became a consultant to the A4M and continues to consult and lecture on antiaging medicine. Dr. Rosenberg is also a researcher and has started a pharmaceutical company which is developing novel drugs for advanced-stage cancer. His company merged with a spin-out of Harvard and has recently gone public.

Dr. Rosenberg avidly scours the literature to stay on the cutting edge of medicine. All who know Dr. Rosenberg are aware that he, “walks the talk.” Dr. Rosenberg eats mostly a plant-based diet and exercises and meditates daily. Being an expert in nutraceutical supplementation, Dr. Rosenberg consumes multiple supplements daily. His primary objective: educate the masses to significantly improve health span and life span.

Curriculum Vitae for Mark Rosenberg, MD, FACEP

Education

• July 1990 – July 1993 Emergency Medicine Residency
  Brooke Army Medical Center
  Dept. of Emergency Medicine
  San Antonio, TX
• July 1988 – July 1989 Transitional Internship
  Fitzsimons Army Medical Center
  Aurora, CO
• July 1984 – May 1988 Doctor of Medicine
  Georgetown University School of Medicine
  Washington, DC
• July 1982 – June 1983 Master of Science in Physiology
  Georgetown University Graduate School
  Washington, DC
• Sept 1978 – May 1982 Bachelor of Arts in Biology
  University of Pennsylvania
  Philadelphia, PA

Committees/Advisory Board

• 2020 – Present; Advisor to Suncoast Sciences
• 2019 – Present; Advisor/Consultant to Hillstream Biopharma (oncology pharmaceutical company)
• 2014 – 2019; Co-founder and Chief Science Officer for Channel Therapeutics and HighPoint Therapeutics (oncology pharmaceutical companies)
• 2014 – Present; Medical Director of Education and Advisory Board Member for Tarsus Medical Group
• 2011 – 2016; Medical Advisor to Life Length Telomere Analysis Technology
• 2003 – 2005; Chairman of Pharmacy and Therapeutics Committee, Bethesda Memorial Hospital
• 2003 – 2005; Institutional Review Board, Bethesda Memorial Hospital
• 2003 – 2007; Consultant to the National Strength and Conditioning Assoc.
• 2000 – 2005; Emergency Department Committee, Bethesda Memorial Hospital
• 1999 – Present; Medical Advisor to Fitness Institute International
• 1990 – 2010; American College of Emergency Physicians

Certifications

• 2009; Board Certified, American Academy of Anti-aging Medicine
• 2001; Diplomate of the American Academy of Anti-aging Medicine
• 1996; Fellow of the American College of Emergency Physicians
• 1994; Board-Certified by the American Board of Emergency Medicine
• 1989; Diplomate of the National Board of Medical Examiners
• 1989 – 1999; ATLS Provider and Instructor, American College of Surgeons
• 1990 – 1992; PALS Provider, American Academy of Pediatrics
• 1988 – Present; ACLS Provider, American Heart Association
• 1998; Certified Hypnotherapist, National Guild of Hypnotists
• 1998; Certified Personal Trainer, National Strength and Conditioning Assoc.

Awards

• 1989; US Army Certificate of Achievement Award, for performance above and beyond the call of duty during the tornado disaster in Alabama
• 1989; US Army Commendation Medal
• 1993; Award for Outstanding Senior Resident and Teacher
• 1999; Valedictorian and Distinguished Speaker, Fitness Institute International
• 1999; Cover of the monthly journal, “The Florida Hypnotist”

Publications

• Epstein A, Zhang D, Schultz J, Rosenberg M, Kupcha P, Stellar E:
  The Failure of Ventricular Sodium to Control Sodium Appetite in the Rat;
  Journal of Physiology and Behavior.32:683-686, 1984
• Rosenberg, Mark A: Toxndex, Toxicological Emergency Reference Manual;
  Delray Beach, FL, MQ INC, 1991
• Rosenberg, Mark A; Williams, Jason; Image guided cryoablation of cancer with intra-tumoral injection of anti-CTLA-4 and PD-1 immune check-point inhibitors; J Immunother Cancer. 2015; 3(Suppl 2): P142

Research Experience

• Currently completing pre-clinical studies (with Harvard affiliates) with a novel drug targeting cancer stem cells. Anticipated date on phase I human trial – 1st quarter 2024.
• Completed pre-clinical studies (with Univ. of Minnesota) with novel monocarboxylate transporters for glycolytic cancers.
• Development of “Cancer Cocktail;” U.S. Application Serial No. 13/464,896
  Title: Cytotoxic Therapy By Proton Flux Modulation; Date Filed: May 4, 2012
• Outcompeting Cancer with Cancer; Study performed at the University of Alabama;proof of concept that a low grade cancer can out-compete a high grade cancer; animalstudy to begin in 2015 to test the hypothesis that an aggressive cancer can be replaced with a manageable, low grade cancer; Provisional patent application file 9/17/14
• IND status granted Feb 24, 2007 for use of angiotensin II to improve tumor blood flow during administration of cytotoxic cancer therapy
• 2007 – Wake Forest University in-vitro study; Inhibition of tumor growth in mice through glycolytic inhibition
• 2009 – University of Miami in-vitro study ; Inhibition of cancer growth (in vitro) through inhibition of proton pump and monocarboxylate transporters

Professional Experience

• 2017 – 2019; Chief Medical Officer; Laboratory for Advanced Medicine
• 2016 – 2019; Co-founder HighPoint Therapeutics, LLC (oncology pharmaceutical company)
• 2015 – 2019; Co-founder and Chief Medical Officer; Channel Therapeutics, LLC (oncology pharmaceutical company)
• 2014 – Present; Medical Director; Advanced Medical Therapeutics
• 2012 – 2014; Medical Director; AML Diagnostics (diagnostic laboratory)
• 2012 – Present; Board of Directors; American Academy of Anti-aging medicine
• 2011 – 2016; Medical Advisor to Life Length Telomere Analysis Technology
• 2010 – 2012; Medical Director; Age Diagnostic Laboratories
• 2009 – Present; Program Director; Integrative Cancer fellowship
• 2008 – 2014; Chief Medical Officer; Rose Pharmaceuticals
• 2006 – 2010; Chief Science Officer and Director of research and Development; Vitalmax Vitamins
• 2003 – 2009; President and Medical Director, The Institute for Healthy Aging, Delray Beach, FL
• 2003 – 2004; Chief Science Officer and Director of Research and Development, “Nutrophy”, Miami, FL
• 1999 – 2005; Assistant Director of Emergency Medicine, Bethesda Memorial Hospital, Boynton Beach, FL
• 1996 – 1999; Associate Director of Emergency Medicine and Director of Quality Improvement, Westside Regional Medical Center, Plantation, FL
• 1993 – 1996; Assistant Chief of Emergency Medicine; Consultant for Poisons and Overdoses; Director of Quality Improvement, Walter Reed Army Medical Center, Washington, DC
• 1995 – 1996; Staff Emergency Physician, Shady Grove AdventistHospital, Rockville, MD
• 1994 – 1996; Staff Emergency Physician, Sibley Memorial Hospital, Washington, DC
• 1993 – 1995; Staff Emergency Physician, Alexandria Hospital Alexandria, VA
• 1989 – 1990; Staff Emergency Physician, Fox Army Community Hospital, Redstone Arsenal, AL